Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

REVB Revelation Biosciences, Inc. Common Stock
$3.50 -7.65% -0.29
Notify me if price changes either direction
Interactive Brokers Logotype

Buy REVB stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Revelation Biosciences, Inc. Common Stock (REVB)

Loading

Key Stats

Market cap. 2.0M
Enterprise value -8586142
Trailing PE 0.117373794
Forward PE -0.18734553
PEG Ratio -0.0011860040301838
Enterprise to EBITDA 0.764
Price to book MRQ 0.2102052

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
EBITDA -11241206
Diluted EPS TTM 32.29
Total Cash (MRQ) 11.5M
Current ratio (MRQ) 6.214
Operating Cash Flow (TTM) -9327937

REVB trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent REVB News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.